GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bloomage BioTechnology Corp Ltd (SHSE:688363) » Definitions » Margin of Safety % (DCF Dividends Based)

Bloomage BioTechnology (SHSE:688363) Margin of Safety % (DCF Dividends Based) : -562.89% (As of Apr. 24, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Bloomage BioTechnology Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2025-04-24), Bloomage BioTechnology's Predictability Rank is 4.5-Stars. Bloomage BioTechnology's intrinsic value calculated from the Discounted Dividend model is ¥21.47 and current share price is ¥47.33. Consequently,

Bloomage BioTechnology's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is -562.89%.


Competitive Comparison of Bloomage BioTechnology's Margin of Safety % (DCF Dividends Based)

For the Specialty Chemicals subindustry, Bloomage BioTechnology's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bloomage BioTechnology's Margin of Safety % (DCF Dividends Based) Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Bloomage BioTechnology's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Bloomage BioTechnology's Margin of Safety % (DCF Dividends Based) falls into.


;
;

Bloomage BioTechnology Margin of Safety % (DCF Dividends Based) Calculation

Bloomage BioTechnology's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)=(Intrinsic Value: DCF (Dividends Based)-Current Price)/Intrinsic Value: DCF (Dividends Based)
=(7.14-47.33)/7.14
=-562.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.


Bloomage BioTechnology Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of Bloomage BioTechnology's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


Bloomage BioTechnology Business Description

Traded in Other Exchanges
N/A
Address
No. 678 Tianchen Avenue, High-Tech Development Zone, Shandong Province, Jinan City, CHN
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid sodium, or HA. The firm organizes itself into two segments based on product type. The HA raw materials segment, which generates the majority of revenue, sells HA and HA derivatives produced using bio-fermentation technology. The HA raw materials segment products are classified into three grades of HA: medicine grade, cosmetic grade, and food grade. The HA end products segment sells medical skin care products, bone products for intra-articular injection, and medical beauty devices. The majority of revenue comes from China.
Executives
Zhao Yi Core technical personnel
Luan Yi Hong Core technical personnel
Shi Yan Li Core technical personnel
Liu Jian Jian Core technical personnel
Wang Yu Ling Core technical personnel
Zhou Wei Core technical personnel
Huang Si Ling Core technical personnel
Han Hong Ling Core technical personnel
Lu Zhen Core technical personnel

Bloomage BioTechnology Headlines

No Headlines